Literature DB >> 22804914

Glabellar contraction patterns: a tool to optimize botulinum toxin treatment.

Ada R Trindade de Almeida1, Elisa R M da Costa Marques, Raul Banegas, Bogdana V Kadunc.   

Abstract

BACKGROUND: Botulinum toxin is a well-established treatment for dynamic glabellar lines. A previous study evaluated the existence of glabellar contraction "patterns," according to the predominance of eyebrow approximation, depression, or elevation movements, namely "U," "V," "convergent arrows," "omega," and "inverted omega."
OBJECTIVES: To confirm contraction patterns in the adult population for a better treatment approach and to verify whether changes occur after repeated treatment.
METHODS: Pairs of photographs-at rest and under contraction-from two groups were retrospectively analyzed: 334 adult volunteers with a predominance of specific movements, being verified and 36 previously treated individuals when they returned for re-injections.
RESULTS: The five glabellar contraction patterns were confirmed. Each individual's initial pattern reappeared upon waning of the toxin effect.
CONCLUSION: Interpersonal differences in facial animation are observed. Classifying glabellar wrinkles allows accurate treatment with botulinum toxin, injecting the most commonly recruited muscles with higher doses or into more sites. Muscles not so recruited are spared or injected with lower doses for more-effective and -natural results. Although botulinum toxin blockade causes recruitment of adjacent muscles, the initial muscle contraction pattern is resumed when the effect wanes.
© 2012 by the American Society for Dermatologic Surgery, Inc. Published by Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22804914     DOI: 10.1111/j.1524-4725.2012.02505.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  10 in total

Review 1.  COMMENTARY ON BOTULINUM TOXIN INJECTIONS: A CALL FOR IMPROVED ACCURACY.

Authors:  Steven G Yoelin; Marilyn S Kwolek; Jon E Block
Journal:  J Clin Aesthet Dermatol       Date:  2020-08-01

Review 2.  Global Aesthetics Consensus: Botulinum Toxin Type A--Evidence-Based Review, Emerging Concepts, and Consensus Recommendations for Aesthetic Use, Including Updates on Complications.

Authors:  Hema Sundaram; Massimo Signorini; Steven Liew; Ada R Trindade de Almeida; Yan Wu; André Vieira Braz; Steven Fagien; Greg J Goodman; Gary Monheit; Hervé Raspaldo
Journal:  Plast Reconstr Surg       Date:  2016-03       Impact factor: 4.730

3.  Tailored botulinum toxin type A injections in aesthetic medicine: consensus panel recommendations for treating the forehead based on individual facial anatomy and muscle tone.

Authors:  Javier Anido; Daniel Arenas; Cristina Arruabarrena; Alfonso Domínguez-Gil; Carlos Fajardo; Mar Mira; Javier Murillo; Natalia Ribé; Helga Rivera; Sofia Ruiz Del Cueto; Helder Silvestre; Marisa Tirado
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-10-19

Review 4.  Neurophysiological Measures of Efficacy and Safety for Botulinum Toxin Injection in Facial and Bulbar Muscles: Special Considerations.

Authors:  Mohammad Alimohammadi; Anna Rostedt Punga
Journal:  Toxins (Basel)       Date:  2017-10-30       Impact factor: 4.546

5.  Assessment of Subject and Physician Satisfaction after Long-Term Treatment of Glabellar Lines with AbobotulinumtoxinA (Dysport®/Azzalure®): Primary Results of the APPEAL Noninterventional Study.

Authors:  Elena Gubanova; May Haddad Tabet; Yvonne Bergerova; Olena Moiseieva; Andrey Chemeris; Elena Sanches; Alisa Sharova; Luisa Rodriguez Pose; Romain Raymond; Inna Prygova; Ian Carlisle
Journal:  Aesthetic Plast Surg       Date:  2018-08-17       Impact factor: 2.326

6.  A Retrospective Study of Chinese-Specific Glabellar Contraction Patterns.

Authors:  Daniel Meng-Yen Hsieh; Shaomin Zhong; Xinyun Tong; Chen Yuan; Li Yang; Anna Yuan Yao; Cheryl Zhou; Yan Wu
Journal:  Dermatol Surg       Date:  2019-11       Impact factor: 3.398

7.  OnabotulinumtoxinA for the treatment of major depressive disorder: a phase 2 randomized, double-blind, placebo-controlled trial in adult females.

Authors:  Mitchell F Brin; Suresh Durgam; Arlene Lum; Lynn James; Jeen Liu; Michael E Thase; Armin Szegedi
Journal:  Int Clin Psychopharmacol       Date:  2020-01       Impact factor: 2.023

8.  The One21 Technique: An Individualized Treatment for Glabellar Lines Based on Clinical and Anatomical Landmarks.

Authors:  Carla de Sanctis Pecora; Maria Valéria Bussamara Pinheiro; Karin Ventura Ferreira; Gisele Jacobino de Barros Nunes; Hélio Amante Miot
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-02-02

9.  OnabotulinumtoxinA Treatment for Moderate to Severe Forehead Lines: A Review.

Authors:  Koenraad De Boulle; Alastair Carruthers; Nowell Solish; Jean Carruthers; Wolfgang G Phillipp-Dormston; Steven Fagien; Sara Sangha; Michael Silberberg; Cheri Mao
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-03-20

10.  Anatomical Injection Guidelines for Glabellar Frown Lines Based on Ultrasonographic Evaluation.

Authors:  Soo-Bin Kim; Hyoung-Moon Kim; Haeryun Ahn; You-Jin Choi; Kyung-Seok Hu; Wook Oh; Hee-Jin Kim
Journal:  Toxins (Basel)       Date:  2021-12-25       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.